TERAPIE VENETOCLAX + AZACYTIDIN U PACIENTŮ S AKUTNÍ MYELOIDNÍ LEUKEMIÍ (AML) VEDE JEN ZŘÍDKA K ELIMINACI LEUKEMICKÉHO KLONU, I KDYŽ JE PŘÍTOMNA MORFOLOGICKÁ REMISE

Investor logo

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English VENETOCLAX + AZACYTIDINE THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA (AML) RARELY RESULTS IN THE ELIMINATION OF THE LEUKAEMIC CLONE, EVEN WHEN MORPHOLOGICAL REMISSION IS PRESENT
Authors

MAYER Jiří JEŽÍŠKOVÁ Ivana SEMERÁD Lukáš KLEMEŠOVÁ Iveta VAŠÍKOVÁ Alžběta FOLTA A. DRNCOVÁ Marie PODSTAVKOVÁ N. KABUT Tomáš MRKVOVÁ Zuzana VOLDŘICH Jakub DIATKOVÁ Jana HOLEČKOVÁ Viktória KVETKOVÁ Anežka PROCHÁZKOVÁ Jiřina BORSKÝ Marek WEINBERGEROVÁ Barbora

Year of publication 2024
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description VENETOCLAX + AZACYTIDINE THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA (AML) RARELY RESULTS IN THE ELIMINATION OF THE LEUKAEMIC CLONE, EVEN WHEN MORPHOLOGICAL REMISSION IS PRESENT - conference abstract.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info